Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/26/2025

Management of Gastrointestinal Infection with Leukocytosis, Hidden Blood, Hypokalemia, and Hyperglycemia

Evaluation and Diagnosis

  • The presence of elevated fecal leukocytes (35-40/field) and positive occult blood indicates an inflammatory intestinal process of bacterial origin, with likely pathogens including Campylobacter jejuni, Salmonella, Shigella, Yersinia, and invasive strains of E. coli 1, 2
  • Elevated PCR (12.0) and leukocytosis (7.7 with 70.2% neutrophils) confirm a systemic inflammatory response that justifies antibiotic intervention 1
  • The American College of Gastroenterology recommends obtaining stool cultures for Salmonella, Shigella, Campylobacter, and Yersinia before starting antibiotics 1, 4

Immediate Management

  • The Infectious Diseases Society of America recommends initiating oral rehydration with low-osmolarity solutions immediately, without waiting for culture results, to replace losses and maintain hydration 1, 3
  • The Centers for Disease Control and Prevention suggest evaluating hydration status through skin turgor, mental status, mucous membranes, capillary refill, and vital signs 1
  • The American College of Emergency Physicians recommends correcting hypokalemia with oral potassium supplementation (40-80 mEq/day divided into doses) if the patient can tolerate oral intake 1

Antibiotic Therapy

  • The American College of Gastroenterology recommends empirical antibiotic therapy with ciprofloxacin 500 mg orally every 12 hours for 3-5 days (first option in adults) or azithromycin 500 mg on day 1, then 250 mg/day for 4 days (alternative, especially if local resistance to quinolones or suspected Campylobacter) 2, 6
  • The Infectious Diseases Society of America advises against administering antibiotics if E. coli O157:H7 is confirmed, as they can precipitate hemolytic uremic syndrome 1, 4

Specific Management by Pathogen

  • If Shigella is confirmed, the Centers for Disease Control and Prevention recommend treatment with azithromycin or ciprofloxacin (if susceptible) to reduce duration and fecal elimination 6, 4
  • If Salmonella non-typhoidal is confirmed, treatment is only recommended for certain high-risk groups, such as those under 6 months, immunocompromised individuals, or those with signs of systemic dissemination or severe disease 6, 4

Monitoring and Follow-up

  • The American College of Gastroenterology recommends monitoring frequency of bowel movements, stool characteristics, temperature, vital signs, and hydration status 1
  • The Infectious Diseases Society of America suggests repeating electrolyte tests in 24-48 hours to confirm correction of hypokalemia and hyponatremia 1
  • The Centers for Disease Control and Prevention advise reevaluating glucose levels after fasting to rule out diabetes mellitus 1

REFERENCES